AXSM FY 2018 Earnings — Axsome Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AXSMAxsome Therapeutics, Inc.

$8B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$48,935

Operating Income

-$33M

Net Income

-$31M

EPS (Diluted)

$-1.15

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$15M

Total Liabilities

$14M

Stockholders' Equity

$937,921

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$48,935	-$42,557	-15.0%
Operating Income	-$33M	-$27M	-20.9%
Net Income	-$31M	-$29M	-7.0%